Jefferies Initiates Coverage on Relmada Therapeutics with Buy Rating, PT $9

lunes, 22 de diciembre de 2025, 7:32 am ET1 min de lectura
RLMD--

Jefferies Initiates Coverage on Relmada Therapeutics with Buy Rating, PT $9

Jefferies Initiates Coverage on Relmada Therapeutics with Buy Rating, PT $9

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios